Literature DB >> 29887609

Reduced oxygen concentration for the resuscitation of infants with congenital diaphragmatic hernia.

John S Riley1, Ryan M Antiel1, Natalie E Rintoul1, Anne M Ades1, Lindsay N Waqar1, Nan Lin2, Lisa M Herkert1, Jo Ann D'Agostino3, Casey Hoffman3, William H Peranteau1, Alan W Flake1, N Scott Adzick1, Holly L Hedrick4.   

Abstract

OBJECTIVE: To evaluate whether infants with congenital diaphragmatic hernia (CDH) can be safely resuscitated with a reduced starting fraction of inspired oxygen (FiO2) of 0.5. STUDY
DESIGN: A retrospective cohort study comparing 68 patients resuscitated with starting FiO2 0.5 to 45 historical controls resuscitated with starting FiO2 1.0.
RESULTS: Reduced starting FiO2 had no adverse effect upon survival, duration of intubation, need for ECMO, duration of ECMO, or time to surgery. Furthermore, it produced no increase in complications, adverse neurological events, or neurodevelopmental delay. The need to subsequently increase FiO2 to 1.0 was associated with female sex, lower gestational age, liver up, lower lung volume-head circumference ratio, decreased survival, a higher incidence of ECMO, longer time to surgery, periventricular leukomalacia, and lower neurodevelopmental motor scores.
CONCLUSION: Starting FiO2 0.5 may be safe for the resuscitation of CDH infants. The need to increase FiO2 to 1.0 during resuscitation is associated with worse outcomes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29887609     DOI: 10.1038/s41372-017-0031-5

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  8 in total

Review 1.  Optimal oxygenation and role of free radicals in PPHN.

Authors:  Stephen Wedgwood; Robin H Steinhorn; Satyan Lakshminrusimha
Journal:  Free Radic Biol Med       Date:  2019-04-14       Impact factor: 7.376

2.  Outcomes of neonatal congenital diaphragmatic hernia in a non-ECMO center in a middle-income country: a retrospective cohort study.

Authors:  Lucy Chai See Lum; Tindivanum Muthurangam Ramanujam; Yee Ian Yik; Mei Ling Lee; Soo Lin Chuah; Emer Breen; Anis Siham Zainal-Abidin; Srihari Singaravel; Conjeevaram Rajendrarao Thambidorai; Jessie Anne de Bruyne; Anna Marie Nathan; Surendran Thavagnanam; Kah Peng Eg; Lucy Chan; Mohamed E Abdel-Latif; Chin Seng Gan
Journal:  BMC Pediatr       Date:  2022-07-07       Impact factor: 2.567

3.  Initiating resuscitation before umbilical cord clamping in infants with congenital diaphragmatic hernia: a pilot feasibility trial.

Authors:  Elizabeth E Foglia; Anne Ades; Holly L Hedrick; Natalie Rintoul; David A Munson; Julie Moldenhauer; Juliana Gebb; Bonnie Serletti; Aasma Chaudhary; Danielle D Weinberg; Natalie Napolitano; María Victoria Fraga; Sarah J Ratcliffe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2019-08-28       Impact factor: 5.747

Review 4.  Respiratory Support of Infants With Congenital Diaphragmatic Hernia.

Authors:  Emma Williams; Anne Greenough
Journal:  Front Pediatr       Date:  2021-12-24       Impact factor: 3.418

Review 5.  Knowledge Gaps in the Fetal to Neonatal Transition of Infants With a Congenital Diaphragmatic Hernia.

Authors:  Philip L J DeKoninck; Emily J J Horn-Oudshoorn; Ronny Knol; Kelly J Crossley; Irwin K M Reiss
Journal:  Front Pediatr       Date:  2021-12-14       Impact factor: 3.418

Review 6.  Congenital diaphragmatic hernia: a narrative review of controversies in neonatal management.

Authors:  Michelle J Yang; Katie W Russell; Bradley A Yoder; Stephen J Fenton
Journal:  Transl Pediatr       Date:  2021-05

7.  Inhaled Nitric Oxide at Birth Reduces Pulmonary Vascular Resistance and Improves Oxygenation in Preterm Lambs.

Authors:  Satyan Lakshminrusimha; Sylvia F Gugino; Krishnamurthy Sekar; Stephen Wedgwood; Carmon Koenigsknecht; Jayasree Nair; Bobby Mathew
Journal:  Children (Basel)       Date:  2021-05-11

8.  Congenital diaphragmatic hernia: 25 years of shared knowledge; what about survival?

Authors:  Satyan Lakshminrusimha; Payam Vali
Journal:  J Pediatr (Rio J)       Date:  2019-10-17       Impact factor: 2.990

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.